This inventor holds 6 USPTO granted patents. Top assignees: Asahi Kasei Kogyo Kabushiki Kaisha, Toyo Jozo Kabushiki Kaisha. Active years: 1989-1997.
Location History:
- Shizuoka, JP (1989 - 1993)
- Sapporo, JP (1997)
Company Filing History:
3 out of 1,297 
3 out of 95 Years Active: 1989-1997
Title: Satoshi Shuto: Innovator in Pharmaceutical Compounds
Introduction
Satoshi Shuto is a prominent inventor based in Shizuoka, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in developing novel compounds that address critical medical challenges. With a total of 6 patents to his name, Shuto's work has garnered attention for its potential impact on cancer treatment.
Latest Patents
One of Shuto's latest patents involves aminoalkylcyclopropane derivatives, specifically focusing on 5'-trifluoromethyl-2'-deoxy-uridine phospholipid compounds. These compounds are characterized by the formula ##STR1##, where R.sub.1 and R.sub.2 represent C.sub.16-18 long-chain aliphatic acyl groups that can be the same or different. The pharmacologically acceptable salts derived from these compounds have shown effectiveness against 5-FU-resistant tumor cells, demonstrating low toxicity and resistance to inactivation by nucleoside phosphorylase in vivo.
Career Highlights
Throughout his career, Satoshi Shuto has worked with notable companies such as Toyo Jozo Co., Ltd. and Asahi Kasei Corporation. His experience in these organizations has allowed him to refine his expertise in pharmaceutical innovations and contribute to various research projects.
Collaborations
Shuto has collaborated with esteemed colleagues, including Hiromichi Itoh and Kiyofumi Fukukawa. These partnerships have facilitated the exchange of ideas and advancements in their respective fields.
Conclusion
Satoshi Shuto's innovative work in pharmaceutical compounds highlights his dedication to addressing significant medical issues. His contributions continue to pave the way for advancements in cancer treatment and other therapeutic areas.